Registered entities
Janux Therapeutics, Inc.
Reg. No. 6458952United States
Innovation
38 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 814 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 12 |
| 2023 | 23 |
| 2024 | 19 |
| 2025 | 21 |
| 2026 | 7 |
Social engagement
Social engagement: 13.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include RA Capital Management, Avalon Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Private equity | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 4 | 33% |
Hiring activity
Hires periodically
4 roles tracked across 4 of the last 12 months
9 Mar 2026 · Senior/Executive Director, Clinical Pharmacology Lead · San Diego
9 Feb 2026 · Clinical Trial Manager · San Diego
16 Nov 2025 · Senior Manager, Clinical Supply Chain · San Diego
Based on job postings tracked across public sources.
Recent activity
7 May 2026
Milestone
regulatory
17 Feb 2026
Milestone
regulatory
26 Jan 2026
Leadership hire
Chief Medical Officer